Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Patient specific

The number of studies for other countries is limited. Krentz et al. (2003) analyzed the provider costs of providing medical care to patients with HIV/AIDS in Southern Alberta Canada) between April 1995 and April 2001. The authors collected all patient-specific provider costs including the cost of drugs (HIV and non-HIV drugs), outpatient care (including physician costs and laboratory testing), and... [Pg.357]

Patient-specific and modelling-aided clinical treatment could, therefore, become a reality within the first decade of this millennium ... [Pg.140]

In silico models will aid both the standardisation and individualisation of medical care. Standardisation of diagnoses, drug and device descriptions, procedures, etc. will make relevant information more readily and more widely available. On the other hand, advanced models will allow development of patient-specific procedures for diagnosis and treatment. This will move the focus from the treatment of diseases to the curing of patients. [Pg.149]

The Stroke-Thrombolytic Predictive Instrument (Stroke-TPI) has recently been developed in order to provide patient-specific estimates of the probability of a more favorable outcome with rt-PA, and has been proposed as a decision-making aid to patient selection for rt-PA." The estimates from this tool should, however, be treated with caution. The prediction rule is dependent on post hoc mathematical modeling, uses clinical trial data from subjects randomized beyond 3 hours who are not rt-PA-eligible according to FDA labeling and current best practice, and has not been externally validated. It is, therefore, not appropriate to exclude patients from rt-PA treatment based solely on Stroke-TPI predictions. [Pg.48]

Intravenous 0.9% saline (if no contraindications are present) ° 200-300 mL/h initial therapy (patient-specific)... [Pg.162]

An approach to selection of drugs for the treatment of patients with hypertension should be evidence-based with considerations regarding the individual s co-existing disease states, co-prescribed medications, and practical patient-specific issues including costs. [Pg.9]

Based on the information presented, create a care plan for JT s hypertension. This should include (1) goals of therapy, (2) a patient-specific therapeutic plan, and (3) a plan for appropriate monitoring to achieve goals and avoid adverse effects. [Pg.26]

Design an appropriate therapeutic regimen for the management of ischemic heart disease based on patient-specific information. [Pg.63]

Devise a pharmacotherapy treatment plan for a patient undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction given patient-specific data. [Pg.83]

Devise a pharmacotherapy treatment and monitoring plan for a patient with non-ST-segment elevation acute coronary syndrome given patient-specific data. [Pg.83]

If the patient is to be treated at home, dispense to the patient a 5- to 7-day supply of prefilled LMWH or fondaparinux syringes in patient-specific dose. [Pg.158]

Develop an appropriate patient-specific therapeutic plan for acute ischemic stroke. [Pg.161]

Prepare a patient-specific self-monitoring plan and review it with the patient. Educate the patient on the signs and symptoms of asthma deterioration and when and how to take rescue actions. [Pg.230]

Design an appropriate COPD treatment regimen based on patient-specific data. [Pg.231]

Given patient-specific information and the prescribed drug treatment regimen, formulate a... [Pg.269]

Create a patient-specific drug treatment plan based on symptoms, severity, and location of ulcerative colitis or Crohn s disease. [Pg.281]

Assess the effectiveness of (3-blocker therapy by measuring heart rate. Heart rate reduction of 25% from baseline or to 55 to 60 beats/minute is desirable. Ask the patient specific, directed questions regarding adverse effects of p-blockers inquire about symptoms of orthostatic hypotension (e.g., lightheadedness, dizziness, or fainting). [Pg.335]

At each encounter, ask the patient specific questions about adherence to prescribed therapy, dietary restrictions and cessation of alcohol intake. [Pg.335]

The goals of treating spasticity can be patient-specific. For ambulatory patients, reducing spasticity may improve mobility. For bed-bound patients, treating spasticity may relieve pain and... [Pg.439]

Once seizure activity has ceased and the patient has stabilized, review the patient s therapeutic regimen. Evaluate and monitor the serum trough concentrations of AEDs with defined target ranges to determine patient-specific therapeutic ranges. If there is a known cause of SE, simplify the treatment regimen once the underlying cause has been treated. In patients... [Pg.470]

The best time to initiate dopaminergic therapy is controversial and patient-specific. Generally, medication is started when the patient s physical impairment affects quality of life. [Pg.473]

Recommend an appropriate choice of analgesic, dose, and monitoring plan for a patient based on type and severity of pain and other patient-specific parameters. [Pg.487]

Provide the patient specific information regarding actions to take if therapy is ineffective or adverse effects develop. [Pg.511]


See other pages where Patient specific is mentioned: [Pg.929]    [Pg.135]    [Pg.140]    [Pg.146]    [Pg.27]    [Pg.32]    [Pg.123]    [Pg.159]    [Pg.17]    [Pg.21]    [Pg.217]    [Pg.266]    [Pg.362]    [Pg.477]    [Pg.492]    [Pg.560]    [Pg.560]    [Pg.578]   


SEARCH



© 2024 chempedia.info